In MCF-7 cell viability assays, Sclareol had an IC50 of 31.11 μM after 24 h and 27.65 μM after 48 h. Treatment with Sclareol at 30 μM significantly increased early and late-stage apoptotic cells after both 24 and 48 hours. Sclareol also showed an MIC of 50 μg/mL for C. albicans, C. auris, and C. parapsilosis after 24 h. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Sclareol and cell viability in MCF-7 cells
Cell-based study · MCF-7 cells [1]
MCF-7 cells were treated with Sclareol. The cell viability IC50 was 31.11 μM after 24 h and decreased to 27.65 μM after 48 h.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10-150 µM
- Exposure duration
- 24 and 48 h
- Method
- were added
- Vehicle
- ethanol
Methods and source locations
Compound reported in the paper: Sclareol
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Experimental (S11, S13, S14, S15, S17); Results (S62)
Cell viability: Cell viability; comparator: sclareol-free ethanol — Experimental (S13); Results (S62)
Sclareol minimum inhibitory concentration against Candida species
Cell-based study · C. albicans (KCTC7965) [2]
Sclareol was tested against C. albicans in a well plate assay. The reported MIC was 50 μg/mL for C. albicans, C. auris, and C. parapsilosis after 24 h.
Literature-Reported Treatment Conditions
- Treatment concentration
- 3.125–200 µg/mL
- Exposure duration
- at 30 °C for 24 h
- Method
- added into each well of a 96-well plate
- Vehicle
- dimethyl sulfoxide
Methods and source locations
Compound reported in the paper: Sclareol
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Materials and Methods > 2.2. Anti-Fungal Susceptibility Microdilution Assay (S6, S8, S9, S11); 3. Results > 3.1. Sclareol Inhibited the Growth of Candida spp. (S62); Table 2 (T2.h1, T2.h2, T2.r1)
minimum inhibitory concentration (MIC): minimum inhibitory concentration (MIC); comparator: Growth control without sclareol treatment and sterilized medium control — 2. Materials and Methods > 2.2. Anti-Fungal Susceptibility Microdilution Assay (S9); 3. Results > 3.1. Sclareol Inhibited the Growth of Candida spp. (S62); Table 2 (T2.h1, T2.h2, T2.r1)
Sclareol and Apoptosis in MCF-7 Cells
Cell-based study · MCF-7 cells [1]
MCF-7 cells were incubated with Sclareol at 30 μM. Early and late-stage apoptotic cells increased significantly after both 24 and 48 hours.
Literature-Reported Treatment Conditions
- Treatment concentration
- 30 µM
- Exposure duration
- 24 and 48 hours
- Vehicle
- ethanol
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Sclareol
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Experimental (S11, S29, S31); Results (S72); Figure 2 legend (S115)
early and late-stage apoptotic cells: early and late-stage apoptotic cells; comparator: control cells — Results (S72)